Posted by Michael Wonder on 16 Apr 2020
Decision to list terbutaline sulphate powder for inhalation (Bricanyl Turbuhaler) in a new model of the Turbuhaler device
16 April 2020 - PHARMAC is pleased to announce that it has made some changes to the listing of terbutaline sulphate powder for inhalation through an agreement with AstraZeneca:
- A new M3 model of the Bricanyl Turbuhaler device will be listed on 1 May 2020
- The existing M2 model of the Bricanyl Turbuhaler device will be delisted on 1 October 2020
There will be no change to the dose strength of terbutaline sulphate delivered in the new model of the Turbuhaler device.
